https://gw6471inhibitor.com/li....kelihood-of-diabetes
For SIENA, normal aging increased from 0.01%/y at age 30 years to -0.31%/y at age 60 years (-0.11% ± 0.032%/decade, p less then 0.01), whereas MS-specific atrophy reduced from -0.38%/y at age 30 years to -0.12%/y at age 60 years (0.09% ± 0.035%/decade, p = 0.01). Similarly, into the thalamus, normal aging increased from -0.15%/y at age 30 many years to -0.62%/y at age 60 years (-0.16% ± 0.079%/decade, p less then 0.05), and MS-specific atrophy decreased from -0.59%/y a
Like
Comment
Share
